Ernexa Therapeutics (ERNA) vs GRI Bio (GRI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
GRI Bio is the larger company by market cap ($4.0 million vs $3.9 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | ERNA | GRI |
|---|---|---|
| Share price | $2.39 | $1.85 |
| Market cap | $3.90M | $4.04M |
| 1-day change | +6.94% | -2.63% |
| EPS (TTM) | $-14.03 | $-14.32 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $71.50 | $64.12 |
| 52-week low | $2.15 | $1.36 |
| Distance from 52-week high | -96.66% | -97.11% |
| Average volume | 462.76K | 327.86K |
| Shares outstanding | 1.63M | 2.19M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ERNA vs GRI FAQ
Which is bigger, Ernexa Therapeutics or GRI Bio?
GRI Bio (GRI) is larger, with a market capitalization of $4.04M compared with $3.90M for Ernexa Therapeutics (ERNA).
Are Ernexa Therapeutics and GRI Bio in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.